In renal cell carcinoma (RCC), overexpressed micropeptide MIAC significantly reduces the capacity of cells to proliferate and migrate by binding to AQP2 and reducing EREG/EGFR expression in vitro and in vivo [77]. Here, EGFR is linked to renal cell carcinoma.